It'll be interesting to see what RegeneRx does with this patent it's been awarded in Japan. It's a first for them in that country. Anyone know anything more about thymosin β4?

BETHESDA, Md.--(BUSINESS WIRE)--REGENERX BIOPHARMACEUTICALS, INC. (NYSE Alternext:RGN) announced today that it received notice of patent allowance from the Japanese Patent Office for “Inhibition or Reversal of Skin Aging by Actin-Sequestering Peptides”. This patent covers use of thymosin β4 (Tβ4) for promoting improvement of skin conditions including elasticity, and reduction and lightening of age-related skin abnormalities.
Full release